Full-fat dairy: why new research is challenging decades of low-fat advice

For decades, dietary guidelines in much of the world have delivered the same instruction at the dairy aisle: reach for the low-fat or skim option. Full-fat milk, yogurt and cheese were treated as foods to limit, blamed for raising cholesterol and packing on weight because of their saturated fat content. A new 12-week study is now challenging that decades-old advice, finding that adults who ate three servings of full-fat dairy a day showed no meaningful increases in weight, body fat, cholesterol or insulin resistance.
Researchers tracked participants who added three servings of full-fat dairy products — think whole milk, full-fat yogurt and regular cheese, rather than their reduced-fat counterparts — to their daily diet over the 12-week period. At the end of the trial, the group showed no significant changes in body weight, body fat percentage, LDL cholesterol or markers of insulin resistance compared with when they started, despite eating what conventional advice would consider a fattier diet.
The full-fat dairy group did see some measurable benefits. Blood pressure improved over the course of the study, and participants ended up consuming significantly more calcium, protein and vitamin D simply because full-fat dairy products deliver more of those nutrients per serving than their skimmed or reduced-fat versions. Those are exactly the nutrients public health officials in many countries say adults, and particularly older adults, don't get enough of.
The findings feed into a growing body of research suggesting that dairy's saturated fat content alone doesn't tell the whole story of how it affects the body. Nutrition scientists increasingly point to what they call the 'food matrix' — the idea that a nutrient's effect depends on the complex structure of the food carrying it, not just the nutrient in isolation. In dairy, the fat is embedded alongside protein, calcium and other compounds in a way that appears to change how the body processes it, compared with the same amount of saturated fat eaten on its own.
The low-fat dairy doctrine traces back to research from the mid-20th century that linked saturated fat intake to elevated cholesterol and, by extension, heart disease risk. That research shaped national dietary guidelines across North America and Europe for generations, steering shoppers toward skim milk and reduced-fat cheese as the default healthy choice, and pushing full-fat versions toward the margins of the dairy case as an indulgence rather than a staple.
More recent research has complicated that picture. Large studies following people's dairy consumption over years have generally failed to find the clear-cut link between full-fat dairy and cardiovascular disease that the original saturated fat hypothesis predicted. Some have even found the opposite — modest protective associations, particularly with fermented dairy products like yogurt and cheese, whose fermentation process appears to further alter how their fat and other components interact with the body.
Researchers involved in the new study are careful to note its limits. Twelve weeks is short in nutrition science, where cardiovascular outcomes typically take years or decades to show up, and the trial doesn't prove that full-fat dairy prevents disease — only that it didn't produce the harmful metabolic changes conventional advice would have predicted over that period. A single study, however well designed, isn't grounds for overhauling national dietary guidelines built on a much larger body of evidence.
Still, the results add to a broader shift underway in nutrition science, one gradually moving away from villainizing single nutrients like saturated fat in isolation and toward evaluating whole foods and overall dietary patterns instead. Recent revisions to dietary guidance in several countries have already softened blanket warnings against full-fat dairy, acknowledging the accumulating evidence around the food matrix effect.
For consumers, the practical takeaway isn't a license to abandon moderation — three servings a day was the amount tested, not an unlimited allowance, and overall diet quality, not any single food swap, remains what most strongly predicts long-term health. But the findings do suggest that choosing full-fat dairy over skim isn't the metabolic risk it was long assumed to be, and that the extra calcium, protein and vitamin D it delivers may be a meaningful trade-off worth considering.
Larger and longer trials are needed before health authorities revise their guidance outright, and researchers say future studies will need to track cardiovascular outcomes directly, rather than the intermediate markers like cholesterol and insulin resistance used in this trial. For now, though, full-fat dairy's decades-long reputation as a food to avoid looks less settled than it once did.
Read next

E-scooter crashes: why UK trauma centres are treating a growing number of injured children
Three major trauma centres in Liverpool, Manchester and Sheffield say they have treated nearly 500 casualties under 16 from e-scooter crashes, some as young as nine. Trauma doctors say the rise deserves far more attention from parents, retailers and regulators alike.

Polio vaccination in Kashmir: the women trekking miles to reach the last unvaccinated children
In the mountain villages of Pulwama, Kashmir, health workers Shameema and Tanzeela carry insulated vaccine boxes for miles each morning, keeping doses between 2C and 8C as summer temperatures climb to 37C. Their work is part of a vast national campaign to vaccinate every child in India against polio, however remote.

What are organoids, and why UK scientists are growing miniature human organs for drug testing
A new £20m project based in Cambridge is growing miniature human organs and tissues from NHS patients' cells, aiming to improve drug testing and reduce the number of animals used. These lab-grown tissue fragments, called organoids, mimic the structure of a real organ and help researchers understand how a disease varies between patients, and which treatment works best for whom.

Should older adults stop taking statins? What a new study found
Millions of older adults take cholesterol-lowering statins for decades without interruption. A new study found that stopping statins in people over 75 at low risk for heart disease did not increase deaths. The findings apply only to the low-risk, primary-prevention group, not people who have already had a heart attack or stroke.

Lp(a): the hidden genetic heart-disease risk most people never test for
Lipoprotein(a), or Lp(a), is an inherited, cholesterol-related particle that a new study of more than 20,000 people links to a sharply higher risk of stroke and cardiovascular death. Unlike standard cholesterol, Lp(a) levels are set almost entirely by genetics and rarely show up on a routine blood panel.